Fred Alger Management, LLC Tricida, Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$29.6 - $43.71 $296,000 - $437,100
-10,000 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$29.87 - $42.22 $298,700 - $422,200
-10,000 Reduced 50.0%
10,000 $309,000
Q2 2019

Aug 14, 2019
BUY
$31.16 - $39.46 $560,880 - $710,280
18,000 Added 900.0%
20,000 $789,000
Q1 2019

May 14, 2019
BUY
$19.96 - $38.62 $39,920 - $77,240
2,000 New
2,000 $77,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email